Wan-Ting Qiang (Wanting Qiang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Dongjian Chen, Yu Zhu, Zhi Cheng, Songfu Jiang, Haiyan He, Wan-Ting Qiang, Fang Xiang, Xuedong Sun, Juan Du
A five-year follow-up clinical study of the B cell maturation antigen chimeric antigen receptor-T cell therapy HDS269B in patients with relapsed or refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dongjian Chen, Yu Zhu, Zhi Cheng, Songfu Jiang, Haiyan He, Wan-Ting Qiang, Fang Xiang, Xuedong Sun, Juan Du
A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
He-Zhou Guo, Zi-Hua Guo, Shan-He Yu, Li-Ting Niu, Wan-Ting Qiang, Meng-Meng Huang, Yuan-Yuan Tian, Juan Chen, Hui Yang, Xiang-Qin Weng, Yi Zhang, Wu Zhang, Shao-Yan Hu, Jun Shi, Jiang Zhu
Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36-inflammatory monocyte axis. Science advances 7 (41) (2021)